Batich, K., Mitchell, D., Healy, P., Herndon, J., Broadwater, G., Michael, G., Huang, M., Hotchkiss, K., Sanchez-Perez, L., Nair, S., Congdon, K., Norberg, P., Weinhold, K., Archer, G., Reap, E., Xie, W., Shipes, S., Albrecht, E., Peters, K., Randazzo, D., Johnson, M., Landi, D., Desjardins, A., Friedman, H., Vlahovic, G., Reardon, D., Vredenburgh, J., Bigner, D., Khasraw, M., McLendon, R., Thompson, E., Cook, S., Fecci, P., Codd, P., Floyd, S., Reitman, Z., Kirkpatrick, J., Friedman, A., Ashley, D. M., & Sampson, J. (2021). cTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA. Neuro-oncology, 23, vi51. http://access.bl.uk/ark:/81055/vdc_100146090015.0x00002f